Venator Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Venator Management's ELV Position: Q2 2026 in Review
Venator Management reduced its Elevance Health (ELV) stake by 78% in Q2 2026, selling an estimated $5.97M and leaving 4,480 shares worth $1.73M. The position accounts for 0.39% of the portfolio, ranked #21.
Venator Management first reported a position in ELV in Q3 2025 and has held it in 4 quarters since. The position peaked at $9.69M in Q4 2025. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Venator Management held 4,480 shares of Elevance Health worth $1.73M as of Q2 2026.
- Venator Management sold 16,105 Elevance Health shares in Q2 2026, an estimated $5.97M.
- Elevance Health made up 0.39% of Venator Management's portfolio in Q2 2026, its #21 holding.
- Venator Management first reported a position in Elevance Health in Q3 2025 and has held it in 4 quarters since.
- Venator Management's Elevance Health position peaked at $9.69M in Q4 2025.
- 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Venator Management's 13F filing for Q2 2026, filed 13 Aug 2026.